← Toate temele

ADHD

Atenție, impulsivitate și hiperactivitate.

202 articole
Definiții și semne precoce · în curândGhiduri practice · în curândTeste orientative · în curândResurse pentru specialiști · în curând
StudiuADHDÎncredere înaltă30.06.2026

Daily Routines and Habits in Individuals with ADHD: A Scoping Review

This scoping review analyzed literature on routines and habits in ADHD across both children and adults, identifying four main affected domains: sleep hygiene, feeding, physical activity, and sedentary behaviors. The review found significant research gaps, including the absence of validated assessment tools specifically designed for ADHD routines/habits and limited intervention studies, with most research focusing on pediatric rather than adult populations.

StudiuAutism + ADHDÎncredere înaltă30.06.2026

Prevalence and Trends of Developmental Disabilities Among US Children and Adolescents Aged 3 to 17 Years From 2016 to 2024

This epidemiological study analyzed national survey data from 2016–2024 to examine prevalence trends in ADHD, autism spectrum disorder, learning disabilities, intellectual disability, and other developmental delays in US children aged 3–17 years. Results showed significant increases in ADHD, learning disabilities, and autism prevalence, with distinct age patterns, while intellectual disability remained stable, highlighting a growing public health challenge requiring enhanced early identification and research.

StudiuAutism + ADHDÎncredere înaltă27.06.2026

Validation of the German Parent-Report Anxiety Scale for Autistic Children: Addressing Diagnostic Overlap and Autism-Specific Anxiety Patterns

This validation study examined the German version of the Anxiety Scale for Children with Autism Spectrum Disorder-Parent Version (ASC-ASD-P) in 317 youth at an autism clinic, including 120 autistic children, demonstrating excellent internal consistency and convergent validity with established behavioral measures. Autistic youth showed higher anxiety and uncertainty scores than non-autistic peers, confirming the scale's sensitivity to autism-specific anxiety presentations, though some subscales require refinement for broader applicability across the autism spectrum.

StudiuAutism + ADHDÎncredere înaltă26.06.2026

Agomelatine versus escitalopram for depression in people with epilepsy: A randomized controlled trial

This double-blind randomized trial compared agomelatine and escitalopram in 51 people with epilepsy and major depressive disorder, evaluating effects on depression, seizure frequency, sleep, cognition, and quality of life. Both medications improved depression similarly with minimal adverse events; escitalopram showed greater quality-of-life improvement while agomelatine showed better verbal memory outcomes, with no significant effects on seizure frequency in either group.

StudiuADHDÎncredere înaltă26.06.2026

Central sensitization symptoms in children with ADHD and their parents: a case-control study

This case-control study found that children with ADHD reported significantly higher central sensitization (heightened pain and sensory sensitivity) symptoms compared to neurotypical peers, with stronger correlations between central sensitization scores and pain intensity in the ADHD group. Parents of children with ADHD also showed elevated central sensitization symptoms, suggesting potential familial patterns in the co-occurrence of ADHD and central sensitization.

StudiuADHDÎncredere bună26.06.2026

ADHD Diagnosis in Children Using EEG Amplitude Modulation Features and Machine Learning

This study proposes a diagnostic framework for childhood ADHD by extracting amplitude modulation features from EEG signals decomposed via wavelet analysis, achieving 99.46% accuracy with a KNN classifier. The approach integrates conventional and novel AM features, with discriminative information concentrated in gamma/beta bands and frontal brain regions, outperforming previous methods.

StudiuADHDÎncredere înaltă26.06.2026

Face-to-Face vs. Online Behavioral Parent Training for Young Children with ADHD: Comparative Outcomes Study

This randomized controlled trial compared traditional face-to-face and online asynchronous behavioral parent training for young children with ADHD (n=196, mean age 50 months) against a wait-list control, with both formats showing equivalent effectiveness on parent-rated and masked behavioral assessments. Online delivery proved as feasible and acceptable as in-person sessions, suggesting it may reduce access barriers while maintaining therapeutic benefit.

StudiuADHDÎncredere înaltă26.06.2026

Advances in neuroimaging studies of thalamic abnormalities in children with ADHD

This review examines MRI findings showing thalamic structural and functional abnormalities in children with ADHD, including reduced volume in specific nuclei and impaired white matter pathways. Evidence indicates that medications like methylphenidate and atomoxetine can promote normalization of thalamic structure and network connectivity, with thalamic imaging metrics showing promise as biomarkers for genetic risk assessment, clinical subtype classification, and treatment prediction.

StudiuADHDÎncredere bună26.06.2026

Serum Ferritin and Zinc Levels in Children with ADHD: A Case-Control Study from Iraq

This case-control study compared serum ferritin and zinc levels in 66 newly diagnosed, treatment-naive children with ADHD versus 110 healthy controls from Iraq, finding significantly lower levels of both micronutrients in the ADHD group and strong correlation with symptom severity. Low zinc and ferritin were associated with specific ADHD presentations, suggesting potential role of these micronutrients in ADHD pathophysiology, though the study does not establish causation or treatment implications.

StudiuADHDÎncredere bună26.06.2026

Positive Parenting Associated With Higher Resilience in Children With ADHD

This study examined 181 children with ADHD (ages 7-18) and found that higher positive parenting behaviors and peer acceptance were independently associated with greater self-reported resilience. Older age and borderline intellectual functioning were protective factors inversely related to resilience in this population.

StudiuADHDÎncredere înaltă26.06.2026

Domain-Specific Cognitive Vulnerabilities in ADHD: Impact of Comorbid Specific Learning Disorder on WISC-IV Profiles

This retrospective study examined cognitive profiles in 105 children (ages 6-16) with ADHD using WISC-IV testing, comparing those with and without comorbid Specific Learning Disorder. Children with ADHD and comorbid SLD showed significantly lower scores in Verbal Comprehension, Perceptual Reasoning, and Working Memory compared to those with ADHD alone, with Working Memory being consistently the lowest cognitive domain across groups.

StudiuAutism + ADHDÎncredere bună26.06.2026

Symptomatic hyperprolactinemia mimicking pituitary pathology in a child with Landau-Kleffner syndrome and autism spectrum disorder: case report

A 12-year-old girl with autism spectrum disorder, Landau-Kleffner syndrome, and intellectual disability developed galactorrhea, vision problems, and falls while taking risperidone, with laboratory findings showing elevated prolactin (40.2 ng/mL) but normal imaging excluding pituitary tumor. Switching from risperidone to olanzapine resulted in complete symptom resolution and prolactin normalization (2.2 ng/mL) within three months, highlighting the importance of monitoring prolactin levels in children on antipsychotic medication.

PresăADHDÎncredere bună25.06.2026

Scientists discover ancient brain cells that help block distractions

Researchers identified neurons in an ancient brain region that function as a focus filter, enabling selective attention to relevant stimuli. Temporarily disabling these neurons in mice produced ADHD-like distractibility symptoms, which normalized upon reactivation, suggesting a biological mechanism underlying attention regulation.

StudiuADHDÎncredere bună25.06.2026

Efficacy and Safety of SPN-812 (Extended-Release Viloxazine) in Children and Adolescents with ADHD: A Systematic Review and Meta-Analysis

This meta-analysis of five randomized controlled trials involving 1,619 pediatric patients (ages 6-17) demonstrates that SPN-812 at doses of 100, 200, and 400 mg/day significantly improved ADHD symptoms compared to placebo on multiple validated rating scales. SPN-812 at 300 mg/day showed favorable safety profiles with no increased risk of serious adverse events like syncope, though higher doses were associated with increased somnolence and appetite suppression.

StudiuAutism + ADHDÎncredere bună24.06.2026

Effect of Prior Depression Diagnosis on Bipolar Disorder Outcomes: A Retrospective Cohort Study

This retrospective cohort study analyzed 5,595 Japanese patients newly diagnosed with bipolar disorder to examine whether a prior depression diagnosis and its duration affected psychiatric and all-cause hospitalization rates and mortality. Patients with prior depression history showed slightly lower all-cause hospitalization risk (HR=0.87), with duration of preceding depression (≥1 year vs <1 year) not significantly altering psychiatric hospitalization outcomes.

PresăADHDÎncredere bună23.06.2026

Ancient Brainstem Neurons Discovered to Control Attention

Researchers identified an evolutionarily conserved circuit of inhibitory neurons in the brainstem that regulates selective spatial attention. This discovery may enhance understanding of attention mechanisms relevant to conditions like ADHD.